SEC Form 4 · accession 0001140361-18-024591
CHEMBIO DIAGNOSTICS, INC. · CEMI
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Sharon W Klugewicz
Officer — President, Americas
Period of report
May 16, 2018
Accepted (ET)
May 18, 2018 · 12:55 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001092662
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1 | May 16, 2018 | M | 5,000 | $4.50 | A | 21,448 | D | |
| Common StockF1 | May 16, 2018 | F | 2,737 | — | D | 18,711 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Options to purchase common stock | $4.50 | May 16, 2018 | M | 2,500 | D | May 22, 2014 | May 22, 2018 | Common Stock | 2,500 | 0 | D |
| Options to purchase common stock | $4.50 | May 16, 2018 | M | 2,500 | D | May 22, 2015 | May 22, 2018 | Common Stock | 2,500 | 0 | D |
Explanation of responses
- F1The reporting person did not sell any shares of common stock. Rather, the reporting person exercised options to acquire 2,263 shares of common stock by submitting and relinquishing to the issuer options to purchase an additional 2,737 shares of common stock. These additional options to purchase 2,737 shares of common stock constituted the entire exercise price, using the 10-day volume weighted average trading price ended May 15, 2018 of $8.2216. As a result of this transaction, the reporting person increased her stock ownership by 2,263 shares of common stock and reduced the number of options owned by 5,000 (2,263 options exercised plus 2,737 options used to pay the exercise price for the 2,263 options exercised to purchase the 2,263 shares of common stock).